The journal is now published in collaboration
with Lifescience Global
Please visit www.lifescienceglobal.com
for all current and future issues of the journal.
LONG TERM ADMINISTRATION OF HMG-COA-REDUCTASE INHIBITOR
(SIMVASTATIN) AFFECTS BRAIN SEROTONIN NEUROTRANSMISSION
IN MALE RATS
Sadia Saleem, Saida Haider, Fizza Naqvi, Saiqa Tabassum and Darakhshan J Haleem
Neurochemistry and Biochemical Neuropharmacology Research Unit,
Department of Biochemistry, University of Karachi
ABSTRACT
Simvastatin, an important member of statin family is widely prescribed as cholesterol-lowering agent. Like other statins
it acts by inhibiting the rate limiting enzyme 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase, responsible for
the endogenous production of cholesterol which forms an essential part of neuronal cell membranes. Lowering of
cholesterol has been reported to alter the brain chemistry and hence neurotransmission. To understand the association
between low cholesterol and brain serotonin (5-HT) we monitored the effect of oral administration of simvastatin for 4
weeks on brain serotonin levels. Drug treated rats exhibited significantly low plasma cholesterol levels. Brain serotonin
and 5-HIAA (5-hydroxyindole acetic acid) levels were also decreased in drug treated rats. Plasma tryptophan (TRP) was
significantly increased but brain tryptophan levels were significantly decreased in drug treated rats. Weekly food intake
during the entire experimental period was comparable in control and drug treated rats. Results of the present study
suggest that simvastatin induced lowering of cholesterol may be responsible for the decrease in brain 5-HT
neurotransmission and hence may be a cause of depression observed in subjects taking simvastatin to lower cholesterol
levels.
